Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus

J Am Acad Nurse Pract. 2008 Feb;20(2):85-92. doi: 10.1111/j.1745-7599.2007.00290.x.

Abstract

Purpose: This article reviews the evolving epidemiology of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and the appropriate outpatient management of CA-MRSA skin and soft tissue infection. Further, the paper will provide the basis upon which an individualized patient educational plan may be developed.

Data sources: To complete this review, a search of English language publications was conducted through Medline and CINAHL databases (1966-2006).

Conclusions: The epidemiology of CA-MRSA is becoming increasingly complex. Research that addresses the impact of this organism in high-risk populations and within families is urgently needed.

Implications for practice: Nurse practitioners must remain informed of the epidemiology of common and emerging drug-resistant organisms in their patient populations.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Communicable Diseases, Emerging / diagnosis
  • Communicable Diseases, Emerging / epidemiology
  • Communicable Diseases, Emerging / therapy
  • Community-Acquired Infections* / diagnosis
  • Community-Acquired Infections* / epidemiology
  • Community-Acquired Infections* / therapy
  • Cross Infection / diagnosis
  • Cross Infection / epidemiology
  • Cross Infection / therapy
  • Humans
  • Methicillin Resistance*
  • Microbial Sensitivity Tests
  • Molecular Epidemiology
  • Nurse Practitioners / organization & administration*
  • Nurse's Role
  • Nursing Assessment
  • Risk Factors
  • Soft Tissue Infections* / diagnosis
  • Soft Tissue Infections* / epidemiology
  • Soft Tissue Infections* / therapy
  • Staphylococcal Skin Infections* / diagnosis
  • Staphylococcal Skin Infections* / epidemiology
  • Staphylococcal Skin Infections* / therapy
  • Staphylococcus aureus*